NIH PREVENT launches Phase 2 trials to treat Long C19 symptoms - heart rate, indigestion and respiratory rate - using Gamunex-C, an oral Ivabradine, a high salt diet and a compression belt
From here:
“Two phase 2 clinical trials to test the safety and effectiveness of three treatments for adults with autonomic nervous system dysfunction from long COVID have begun.
The autonomic nervous system acts largely unconsciously and regulates bodily functions, such as heart rate, digestion and respiratory rate. Symptoms associated with autonomic nervous system dysfunction have been among those that patients with long COVID say are most burdensome.
The trials are part of the National Institutes of Health’s Researching COVID to Enhance Recovery (RECOVER) Initiative, a nationwide research program to fully understand, diagnose and treat long COVID.
Other RECOVER phase 2 clinical trials testing treatments to address viral persistence and neurological symptoms, including cognitive dysfunction (like brain fog), launched in July 2023.”
Good luck with that! I confess to being a believer in the use of salt – gut feel (sic) only!
Makes you wonder if the control group has not been injected with mRNA but still has long C19?!?
“The trials will initially examine three potential treatments:
Gamunex-C, a form of intravenous immunoglobulin (IVIG), contains antibodies to help the body protect itself against infection from various diseases and is given by intravenous infusion.
Ivabradine, an oral medication that reduces heart rate.
Coordinator-guided, non-drug care, which includes a series of activities managed through weekly phone calls with a care coordinator, such as wearing a compression belt and eating a high-salt diet, which are recommended for patients with POTS to counteract excessive loss of fluids.
Onwards!
Please subscribe ten bucks a month or annually for 100 bucks. You can also donate via Ko-fi – any amount from three bucks upwards. Ko-fi donations here: https://ko-fi.com/peterhalligan